You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Errors in Figures 1 and 5 and Accompanying Legends, for a Sentence in Legends to Figures 2 Through 4, and in Lead Author's Name in Affiliation Footnote

Arch Neurol. 2002;59:202.

In the Original Contribution by Parvathy et al titled "Correlation Between Aßx-40–, Aßx-42–, and Aßx-43–Containing Amyloid Plaques and Cognitive Decline," published in the December issue of ARCHIVES (2001;58:2025-2032), Figure 1 and Figure 5 had errors in the body of the figure and its accompanying legend. We are reproducing the correct figures and legends here (Figure 1 and Figure 5). In the legends to Figures 1 through 5, the sentence that reads "AßC40, AßC42, and AßC43 are antibodies reactive to amyloid ßx-40." should have read: "AßC40, AßC42, and AßC43 are antibodies reactive to amyloid ßx-40, amyloid ßx-42, and amyloid ßx-43, respectively. In addition, the second mention of the lead author's name was misspelled in the affiliation footnote at the bottom left on page 2025. It should have read Dr Parvathy. The ARCHIVES regrets these errors.



View larger version (32K):
[in this window]
[in a new window]
Figure 1. Characterization of antibodies. AßC40, AßC42, and AßC43 are antibodies reactive to amyloid ßx-40, amyloid ßx-42, and amyloid ßx-43, respectively. Specificity of antibodies AßC40, AßC42, and AßC43 was determined by dot blotting (A), immunoblotting (B), and enzyme-linked immunosorbent assay (C). Synthetic Aß1-40, Aß1-42, or Aß1-43 was either spotted on a nitrocellulose membrane (A) or electrophoresed on a Tris-tricine gel and transferred to a nitrocellulose membrane (B). The membranes were probed with the indicated antibodies and detected using horseradish peroxidase–conjugated secondary antibody with enhanced chemiluminescent reagent. In part C indicated amounts of synthetic Aß1-40, Aß1-42, and Aß1-43 peptides were coated onto enzyme-linked immunosorbent assay plates and incubated with antibody. Bound antibody was detected using a calorimetric assay.




View larger version (13K):
[in this window]
[in a new window]
Figure 5. Relative proportion of amyloid ß (Aß) plaque types. The number of cored and diffuse plaques in double-labeled sections stained with either AßC40 and AßC42 (A) or AßC42 and AßC43 (B) antibodies was determined and is given as a percentage of total plaques counted in each condition. In each condition, the number of plaques containing either 1 or 2 Aß variants was determined. AßC40, AßC42, and AßC43 are antibodies reactive to amyloid ßx-40, amyloid ßx-42, and amyloid ßx-43, respectively.




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.